Perioperative management of liver transplantation patients

Current Opinion in Critical Care

Volumn 7, Issue 4, 2001, Pages 275-280

  Mathew, Malcolm C ^a   Wendon, Julia A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIOLOGY; CLINICAL PRACTICE; HUMAN; INTENSIVE CARE UNIT; LIVER TRANSPLANTATION; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; REVIEW; SURGICAL TECHNIQUE;

HUMANS; LIVER TRANSPLANTATION; PERIOPERATIVE CARE;

EID: 0034834789     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200108000-00011     Document Type: Review

References (71)

1. Clinical and pathologic observations after orthotopic transplantation of the human liver
2. Liver transplantation in man I: Observations on technique and organization in five cases
3. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study
4. Split liver transplantation: Kings College Hospital experience
5. In situ split liver transplantation for two adult recipients
6. Living donor liver transplantation: Present and future
7. Hepatic parenchymal transection using ultrasonic coagulating shears: A preliminary report
8. Experimental study of a novel fibrin sealant for achieving haemostasis following partial hepatectomy
9. Piggyback technique and selective use of veno-venous bypass in adult orthotopic liver transplantation
10. Analysis of the complications of the piggy-back technique in 1112 liver transplants
11. Reducing the demand for admission to intensive care after major abdominal surgery by a change in anaesthetic practice and the use of remifentanil
12. Phenylephrine treatment of the postreperfusion syndrome in liver transplantation
13. Liver transplantation: Anaesthesia and perioperative care
14. Coagulopathies in hepatic disease
15. Haemostatic disorders during liver transplantation
16. Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicentre randomised double-blind study
17. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation
18. The effect of aprotinin on renal function in orthotopic liver transplantation
19. Aprotinin: Pharmacological reduction of perioperative bleeding
20. Early vascular complications after pediatric liver transplantation
21. Critical care issues in liver transplantation
22. Intraoperative concerns when a liver recipient is critically ill
23. Extracorporeal blood purification using the MARS-system in ICU-bound patients suffering from liver failure was associated with recovery of liver function
24. Use of MARS in the treatment of acute liver failure: Preliminary monocentric experience
25. Bioartificial liver in the treatment of hepatic failure
26. Procalcitonin in fever of unknown origin after liver transplantation: A variable to differentiate acute rejection from infection
27. Efficacy and safety of recombinant human activated protein C for severe sepsis
28. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: Results of a prospective, randomized, double-blind study
29. Hepatopulmonary syndrome: Recent literature (1997-1999) and implications for liver transplantation
30. Critical care issues: Portopulmonary hypertension
31. Hepatorenal syndrome
32. Readmission to the intensive care unit after liver transplantation
33. Central nervous system complications in liver transplant recipients: Incidence, timing, and long-term follow-up
34. Brain edema and portal-systemic encephalopathy
35. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical trial
36. Neurotoxicity of calcineurin inhibitors: Impact and clinical management
37. Outcome of central pontine and extrapontine myelinolysis
38. Hypothermia and the prevention of cerebral damage in acute liver failure
39. Immunosuppressive strategies in transplantation
40. Microchimerism and rejection: A meta-analysis
41. Towards tolerance: Lessons learned from liver transplantation
42. Intravenous mycophenolate mofetil: Safety, tolerability, and pharmacokinetics
43. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper)
44. Use of Daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function
45. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: A longitudinal study of antimicrobial susceptibility patterns
46. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients
47. Chronic diarrhea as a result of intestinal microsposidiosis in a liver transplant recipient
48. Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial
49. Prophylactic antiviral therapy in CMV high-risk liver transplant recipients
50. Cytomegalovirus immune globulin after liver transplantation: A cost-effectiveness analysis 1
51. Posttransplantation: Emerging and future therapies
52. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization
53. Case studies of the hepatitis B patient: A panel discussion
54. Conquering hepatitis C, step by step
55. Posttransplantation prevention and treatment of recurrent hepatitis C
56. Daily interferon therapy for hepatitis C virus infection in liver transplant recipients
57. Malnutrition in liver disease
58. Nutritional support in children with end-stage liver disease: A randomized crossover trial of a branched-chain amino acid supplement
59. Nonoperative management of bile leaks following liver transplantation
60. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation
61. Effect on outcome of the lengthening waiting list for liver transplantation
62. Early indicators of prognosis in fulminant hepatic failure
63. Fulminant and subfulminant liver failure: Definitions and causes
64. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: A prospective study
65. Acute liver failure: Clinical Features, outcome analysis, and applicability of prognostic criteria
66. Early indicators of prognosis in fulminant hepatic failure: An assessment of the King's criteria
67. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure
68. Use and validation of selection criteria for liver transplantation in acute liver failure
69. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage